ClinicalTrials.gg
Status unknownNCT03694990Updated Oct 3, 2018

Prospective Quality of Life Study in Pituitary Surgery

An observational study in Post Operative Care, Endoscopic Skull Base Surgery and Postoperative Period, sponsored by University of Virginia. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-10-03.

Sponsored by University of Virginia · Observational

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
165
Ages
18 Years and older
Sex
All
01

Study summary

Post-operative assessment and debridement are key components in patient care for surgery patients. However, a standardized protocol for management after endoscopic skull base surgery is unavailable. In this study, investigators will observe the effect of various follow-up schedules on the patient's quality of life after surgery. Patients who received surgery for pituitary adenoma will be placed randomly in 1 of 3 groups (short-term = follow-up in 2 weeks and 8 weeks after surgery; intermediate = 4 weeks and 8 weeks; long-term = 8 weeks). At each visit, patients will be asked to complete a packet of surveys and questionnaires that provide metrics on their quality of life in addition to receiving standard patient care (post-operative assessment and nasal debridement). Researchers hope to find that a follow-up schedule that has patients visiting the clinic closer to their surgery date will increase the patient's quality of life after surgery.

02

Conditions studied

  • Post Operative Care
  • Endoscopic Skull Base Surgery
  • Postoperative Period
03

In context

Lead sponsor

University of Virginia is the lead sponsor of 673 studies on the registry; 139 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 41 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients receiving surgery for pituitary adenoma at UVA after May 1st, 2018.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Has surgery for pituitary adenoma at UVA after May 1st, 2018
  • Has sellar and parasellar pathology
  • ≥ 18 years old
  • Can complete all parts of study in English

Exclusion criteria

Exclusion Criteria:

  • Extended approaches
  • Use of naso-septal flap during the current surgical procedure
  • Septoplasty
  • Prior history of Chronic Rhinosinusitis (CRS)
  • Prior history of sphenoidotomy
  • \< 18 years old
  • Prisoner
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
165 participants (estimated)
Patient registry
No

Groups and cohorts

  • Short-term

    Patients will be scheduled for PO follow-up visits 2 weeks, and 8 weeks after surgery.

    Other: Follow-up schedule

  • Intermediate

    Patients will be scheduled for PO follow-up visits 4 weeks, and 8 weeks after surgery.

    Other: Follow-up schedule

  • Long-term

    Patients will be scheduled for PO follow-up visits 8 weeks after surgery.

    Other: Follow-up schedule

Interventions

  • OtherFollow-up schedule

    Patients will be randomized into 1 of 3 follow-up schedules for post-operative clinic visits.

06

What researchers measure

Primary outcomes

  1. SNOT-22 survey scores for pre-op/initial visit

    Patient responses to the SNOT-22 will be collected and calculated.

    Time frame: Survey results will be collected during the pre-op/initial 1 day visit

  2. SNOT-22 survey scores for 2-week or 4-week follow-up visit

    Patient responses to the SNOT-22 will be collected and calculated.

    Time frame: 2-weeks or 4-weeks after surgery (based on group)

  3. SNOT-22 survey scores for 8-week follow-up visit

    Patient responses to the SNOT-22 will be collected and calculated.

    Time frame: 8-weeks post-op

  4. SNOT-22 survey scores for 3-month contact

    Patient responses to the SNOT-22 will be collected and calculated.

    Time frame: 3-month contact

  5. SNOT-22 survey scores for 6-month follow-up visit

    Patient responses to the SNOT-22 will be collected and calculated.

    Time frame: 6-month post-op

  6. Anterior Skull Base QOL survey scores for pre-op/initial visit

    Patient responses to the Anterior Skull Base QOL will be collected and calculated.

    Time frame: collected during the pre-op/initial 1 day visit

  7. Anterior Skull Base QOL survey scores for 2-week or 4-week follow-up visit

    Patient responses to the Anterior Skull Base QOL will be collected and calculated.

    Time frame: 2-weeks or 4-weeks after surgery (based on group)

  8. Anterior Skull Base QOL survey scores for 8-week follow-up visit

    Patient responses to the Anterior Skull Base QOL will be collected and calculated.

    Time frame: 8-weeks post-op

  9. Anterior Skull Base QOL survey scores for 3-month contact

    Patient responses to the Anterior Skull Base QOL will be collected and calculated.

    Time frame: 3-month contact

  10. Anterior Skull Base QOL survey scores for 6-month follow-up visit

    Patient responses to the Anterior Skull Base QOL will be collected and calculated.

    Time frame: 6-month post-op

  11. Pain Catastrophizing Scale (PCS) response for pre-op/initial visit

    Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated.

    Time frame: collected during the pre-op/initial 1 day visit

  12. Pain Catastrophizing Scale (PCS) response for 2-week or 4-week follow-up visit

    Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated.

    Time frame: 2-weeks or 4-weeks after surgery (based on group)

  13. Pain Catastrophizing Scale (PCS) response for 8-week follow-up visit

    Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated.

    Time frame: 8-weeks post-op

  14. Pain Catastrophizing Scale (PCS) response for 3-month contact

    Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated.

    Time frame: 3-month contact

  15. Pain Catastrophizing Scale (PCS) response for 6-month follow-up visit

    Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated.

    Time frame: 6-month post-op

  16. Questionnaire of Olfactory Disorders survey scores for pre-op/initial visit

    Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated.

    Time frame: collected during the pre-op/initial 1 day visit

  17. Questionnaire of Olfactory Disorders survey scores for 2-week or 4-week follow-up visit

    Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated.

    Time frame: 2-weeks or 4-weeks after surgery (based on group)

  18. Questionnaire of Olfactory Disorders survey scores for 8-week follow-up visit

    Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated.

    Time frame: 8-weeks post-op

  19. Questionnaire of Olfactory Disorders survey scores for 3-month contact

    Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated.

    Time frame: 3-month contact

  20. Questionnaire of Olfactory Disorders survey scores for 6-month follow-up visit

    Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated.

    Time frame: 6-month post-op

  21. Skull Based Inventory scores for pre-op/initial visit

    Patient responses to the Skull Based Inventory will be collected and calculated.

    Time frame: collected during the pre-op/initial 1 day visit

  22. Skull Based Inventory scores for 2-week or 4-week follow-up visit

    Patient responses to the Skull Based Inventory will be collected and calculated.

    Time frame: 2-weeks or 4-weeks after surgery (based on group)

  23. Skull Based Inventory scores for 8-week follow-up visit

    Patient responses to the Skull Based Inventory will be collected and calculated.

    Time frame: 8-weeks post-op

  24. Skull Based Inventory scores for 3-month contact

    Patient responses to the Skull Based Inventory will be collected and calculated.

    Time frame: 3-month contact

  25. Skull Based Inventory scores for 6-month follow-up visit

    Patient responses to the Skull Based Inventory will be collected and calculated.

    Time frame: 6-month post-op

  26. Quality of Recover (QOR 40) survey scores for pre-op/initial visit

    Patient responses to the Quality of Recover (QOR 40) will be collected and calculated.

    Time frame: collected during the pre-op/initial 1 day visit

  27. Quality of Recover (QOR 40) survey scores for 2-week or 4-week follow-up visit

    Patient responses to the Quality of Recover (QOR 40) will be collected and calculated.

    Time frame: 2-weeks or 4-weeks after surgery (based on group)

  28. Quality of Recover (QOR 40) survey scores for 8-week follow-up visit

    Patient responses to the Quality of Recover (QOR 40) will be collected and calculated.

    Time frame: 8-weeks post-op

  29. Quality of Recover (QOR 40) survey scores for 3-month contact

    Patient responses to the Quality of Recover (QOR 40) will be collected and calculated.

    Time frame: 3-month contact

  30. Quality of Recover (QOR 40) survey scores for 6-month follow-up visit

    Patient responses to the Quality of Recover (QOR 40) will be collected and calculated.

    Time frame: 6-month post-op

Secondary outcomes

  1. Physician's notes/Patient progress notes for patient clinic visits

    Notes taken by the physician/medical staff during subject's clinic visit (i.e. lesion pathology, cavernous sinus invasion, suprasellar extension, post-op assessment, presence of nasal synechiae, rate of medpor graft extrusion)

    Time frame: Clinic visit notes and/or patient progress notes will be collected during the pre-op/initial 1 day visit, subsequent follow-up visits (2-weeks, 4-weeks, and 8-weeks post-op), and final visit (6-months post-op).

  2. Endoscopy scores

    Lund-Kennedy scoring of endoscopic imaging of nasal cavity

    Time frame: Endoscopy scores will be collected during the pre-op/initial 1 day visit, subsequent follow-up visits (2-weeks, 4-weeks, and 8-weeks post-op), and final visit (6-months post-op).

  3. Surgery notes/outcomes

    Surgeon's notes on subject surgery (i.e. occurrence of intra-operative leak, type of packing used)

    Time frame: intraoperative

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Tien DA, Stokken JK, Recinos PF, Woodard TD, Sindwani R. Comprehensive Postoperative Management After Endoscopic Skull Base Surgery. Otolaryngol Clin North Am. 2016 Feb;49(1):253-63. doi: 10.1016/j.otc.2015.09.015. PubMed 26614842 ↗
  • Nyquist GG, Rosen MR, Friedel ME, Beahm DD, Farrell CJ, Evans JJ. Comprehensive management of the paranasal sinuses in patients undergoing endoscopic endonasal skull base surgery. World Neurosurg. 2014 Dec;82(6 Suppl):S54-8. doi: 10.1016/j.wneu.2014.07.027. PubMed 25496636 ↗
  • Suberman TA, Zanation AM, Ewend MG, Senior BA, Ebert CS Jr. Sinonasal quality-of-life before and after endoscopic, endonasal, minimally invasive pituitary surgery. Int Forum Allergy Rhinol. 2011 May-Jun;1(3):161-6. doi: 10.1002/alr.20029. Epub 2011 Apr 26. PubMed 22287366 ↗
  • Little AS, Kelly DF, Milligan J, Griffiths C, Prevedello DM, Carrau RL, Rosseau G, Barkhoudarian G, Jahnke H, Chaloner C, Jelinek KL, Chapple K, White WL. Comparison of sinonasal quality of life and health status in patients undergoing microscopic and endoscopic transsphenoidal surgery for pituitary lesions: a prospective cohort study. J Neurosurg. 2015 Sep;123(3):799-807. doi: 10.3171/2014.10.JNS14921. Epub 2015 Apr 17. PubMed 25884256 ↗
  • Woodmansee WW, Carmichael J, Kelly D, Katznelson L; AACE Neuroendocrine and Pituitary Scientific Committee. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE MANAGEMENT FOLLOWING PITUITARY SURGERY. Endocr Pract. 2015 Jul;21(7):832-8. doi: 10.4158/EP14541.DSCR. PubMed 26172128 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2018; primary completion for Oct 2020, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2018
First posted
Oct 3, 2018
StartEst.
Oct 2018
Primary completionEst.
Oct 2020
CompletionEst.
Oct 2020
Last update
Oct 3, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 3, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03694990
Responsible party
Jose Mattos, MD (Principal Investigator, University of Virginia) — Principal investigator
First posted
Oct 3, 2018
Start date
Oct 2018 (estimated)
Primary completion
Oct 2020 (estimated)
Completion
Oct 2020 (estimated)
Last update
Oct 3, 2018

Study contacts

Jose Mattos, MD
Contact
jm6cb@virginia.edu
434-924-5934
Karis Ra, BA
Contact
hr6dz@virginia.edu
703-399-6628
Jose Mattos, MD
principal investigator · University of Virginia School of Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion